SCHEMBL20556587

SCHEMBL20556587

NC(=O)c1nc(Cl)c(-n2nccn2)nc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 5/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ CYP1A2 P05177 5/20 0.43
▸ SLC9A1 P19634 5/20 0.43
▸ TSHR P16473 4/20 0.43
▸ SLC9A5 Q14940 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ CYP2D6 P10635 3/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ TDP1 Q9NUW8 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ADORA2A P29274 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ THPO P40225 2/20 0.43
▸ PMP22 Q01453 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ADORA2B P29275 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17768977 0.87 TDP1 (0.43) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL29907694 0.87 TDP1 (0.43) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL22551928 0.83 NPSR1 (0.40) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL17778177 0.80 ADORA2A (0.41) ALDH1A1SLC9A1LMNAMEN1KMT2A
SCHEMBL14237878 0.76 PLAU (0.50) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL805324 0.74 SCNN1A (0.63) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL31325583 0.74 SCNN1A (0.63) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL17768824 0.72 ADORA2A (0.43) ALDH1A1CYP1A2TSHRCYP2D6CYP2C19
Hydrochloric Acid SCHEMBL11496167 0.72 ALDH1A1 (0.65) PLAUALDH1A1CYP1A2SLC9A1TSHR
SCHEMBL17778186 0.72 ADORA2A (0.39) PLAUALDH1A1CYP1A2SLC9A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472347-B2 Aminopyrazine compounds with A2A antagonist properties MERCK SHARP & DOHME CORP. (US) 2019-11-12 — — US disclosed
US-20180327385-A1 AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME CORP. (US) 2018-11-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10472347-B2 Aminopyrazine compounds with A2A antagonist properties ADORA2A, ADORA1, ADORA3 PLAU 2745/4885ALDH1A1 591/4885CYP1A2 603/4885
US-20180327385-A1 AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES ADORA2A, ADORA1, ADORA3 PLAU 2745/4885ALDH1A1 591/4885CYP1A2 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback